tiprankstipranks
Crispr Therapeutics price target lowered to $67 from $80 at Barclays
PremiumThe FlyCrispr Therapeutics price target lowered to $67 from $80 at Barclays
10d ago
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
11d ago
Crispr Therapeutics highlights ASGCT oral presentation, announces new programs
PremiumThe Fly
Crispr Therapeutics highlights ASGCT oral presentation, announces new programs
11d ago
Crispr Therapeutics call volume above normal and directionally bullish
PremiumThe FlyCrispr Therapeutics call volume above normal and directionally bullish
1M ago
Crispr Therapeutics price target raised to $89 from $88 at Citi
PremiumThe Fly
Crispr Therapeutics price target raised to $89 from $88 at Citi
1M ago
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
PremiumPress Releases
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
2M ago
Crispr Therapeutics proposes to elect Christian Rommel to board of directors
PremiumThe FlyCrispr Therapeutics proposes to elect Christian Rommel to board of directors
2M ago
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
PremiumPress Releases
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
2M ago
Crispr Therapeutics price target raised to $99 from $82 at Mizuho
PremiumThe Fly
Crispr Therapeutics price target raised to $99 from $82 at Mizuho
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100